Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIPLE: NMDA Modulation of Nocebo Effects
NCT04762836Completed
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2021
- Primary completion
- Aug 2021
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of d-cycloserine in pain (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Magnitude of induced nocebo hyperalgesia at Day 1. Started Feb 2021; status: completed.
02
Drugs
d-cycloserine
03
Conditions
pain
Beyond the preview
Go deeper on NCT04762836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04762836.